Okada H - Search Results

1

Prevention of biliary complication in radiofrequency ablation for hepatocellular carcinoma-Cooling effect by endoscopic nasobiliary drainage tube.

Ogawa T, Kawamoto H, Kobayashi Y, Nakamura S, Miyatake H, Harada R, Tsutsumi K, Fujii M, Kurihara N, Kato H, Hirao K, Mizuno O, Ishida E, Okada H, Yamamoto K. Ogawa T, et al. Among authors: okada h. Eur J Radiol. 2010 Feb;73(2):385-90. doi: 10.1016/j.ejrad.2008.10.021. Epub 2008 Dec 3. Eur J Radiol. 2010. PMID: 19056192 Clinical Trial.

2

Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor.

Okada N, Harada R, Okada H. Okada N, et al. Among authors: okada h. Clin Exp Immunol. 1990 Apr;80(1):109-13. doi: 10.1111/j.1365-2249.1990.tb06449.x. Clin Exp Immunol. 1990. PMID: 1691059 Free PMC article.

3

Purification of 1F5 antigen that prevents complement attack on homologous cell membranes.

Harada R, Okada N, Fujita T, Okada H. Harada R, et al. Among authors: okada n, okada h. J Immunol. 1990 Mar 1;144(5):1823-8. J Immunol. 1990. PMID: 2307842

4

Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement.

Okada N, Harada R, Fujita T, Okada H. Okada N, et al. Among authors: okada h. J Immunol. 1989 Oct 1;143(7):2262-6. J Immunol. 1989. PMID: 2476502

5

A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement.

Okada N, Harada R, Fujita T, Okada H. Okada N, et al. Among authors: okada h. Int Immunol. 1989;1(2):205-8. doi: 10.1093/intimm/1.2.205. Int Immunol. 1989. PMID: 2487685

6

Complete deficiency of 20 KDa homologous restriction factor (HRF20) and restoration with purified HRF20.

Okada N, Harada R, Taguchi R, Okada H. Okada N, et al. Among authors: okada h. Biochem Biophys Res Commun. 1989 Oct 16;164(1):468-73. doi: 10.1016/0006-291x(89)91743-9. Biochem Biophys Res Commun. 1989. PMID: 2803313

7

A new group of antibiotics, hydroxamic acid antimycotic antibiotics. II. The structure of neoenactins NL1 and NL2 and structure-activity relationship.

Okada H, Yamamoto K, Tsutano S, Inouye Y, Nakamura S, Furukawa J. Okada H, et al. J Antibiot (Tokyo). 1989 Feb;42(2):276-82. doi: 10.7164/antibiotics.42.276. J Antibiot (Tokyo). 1989. PMID: 2925518 Free article.

8

Hydroxamic acid antimycotic antibiotics. A new group of antibiotics.

Inouye Y, Okada H, Nakamura S. Inouye Y, et al. Among authors: okada h. Ann N Y Acad Sci. 1988;544:180-2. doi: 10.1111/j.1749-6632.1988.tb40400.x. Ann N Y Acad Sci. 1988. PMID: 3214067 No abstract available.

9

A new group of antibiotics, hydroxamic acid antimycotic antibiotics. I. Precursor-initiated changes in productivity and biosynthesis of neoenactins NL1 and NL2.

Okada H, Yamamoto K, Tsutano S, Nakamura S. Okada H, et al. J Antibiot (Tokyo). 1988 Jul;41(7):869-74. doi: 10.7164/antibiotics.41.869. J Antibiot (Tokyo). 1988. PMID: 3417560 Free article.

10

Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease.

Okada H, Mizuno M, Yamamoto K, Tsuji T. Okada H, et al. Acta Med Okayama. 1996 Oct;50(5):227-35. doi: 10.18926/AMO/30499. Acta Med Okayama. 1996. PMID: 8914675 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,634 results

Search Page

Filters